Eribulin Mesylate 0.44 mg/mL Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 0.44 mg/mL
Reference Brands: HALAVEN (USA/EU)
Category: Oncology Cancer Care
Eribulin mesylate is a microtubule dynamics inhibitor derived from the marine sponge Halichondria okadai. It is used for the treatment of patients with metastatic breast cancer and unresectable or metastatic liposarcoma who have received prior chemotherapy. The drug works by inhibiting microtubule growth, leading to cancer cell cycle arrest and apoptosis. Halaven is administered intravenously under medical supervision and is recognized for extending survival in patients with advanced cancer.
Eribulin Mesylate — third party manufacturing & bulk supply
Eribulin Mesylate 0.44 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Eribulin Mesylate is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Eribulin Mesylate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Eribulin Mesylate →Frequently Asked Questions
Eribulin mesylate is used to treat patients with metastatic breast cancer and unresectable or metastatic liposarcoma who have received prior chemotherapy. It works by inhibiting microtubule dynamics in cancer cells, which leads to cell cycle arrest and apoptosis, helping to slow or stop tumor growth.
Eribulin mesylate is made from a synthetic analog of halichondrin B, a compound originally derived from the marine sponge Halichondria okadai. It is a microtubule dynamics inhibitor that targets cancer cells.
The trade name of Eribulin mesylate is Halaven.
Eribulin mesylate (Halaven) is manufactured by Eisai Co., Ltd. and marketed globally in collaboration with other licensed pharmaceutical distributors.
The generic name of Eribulin mesylate is Eribulin mesylate.
The brand name of Eribulin mesylate is Halaven.
Eribulin mesylate is manufactured in Japan and other countries by Eisai Co., Ltd. under strict GMP-certified conditions for oncology therapeutics.
Related Products
Epcoritamab-Bysp
Strength:
4 mg/0.8 mL, 48 mg/0.8 mL
Form: Injection
Reference Brands: EPKINLY (USA)
View Details
Epirubicin
Strength:
10 mg/5 mL, 50 mg/25 mL, 200 mg/100 mL
Form: Injection
Reference Brands: Ellence®(US); Farmorubicin®(EU)
View Details
Erlotinib
Strength:
25 mg, 100 mg, 150 mg
Form: Oral Tablets
Reference Brands: Tarceva (US & EU), Erlocip (India)
View Details
Etoposide
Strength:
Injection: 20 mg/mL; Capsule: 50 mg
Form: Oral Capsules & Injection:
Reference Brands: US: Toposar® (injection) VePesid® (capsules); EU: Etopophos® (injectable phosphate form) Vepesid® (capsules)
View Details
Fludarabine Phosphate
Strength:
Injection: 25 mg/ml; Tablet: 10 mg
Form: Injection (IV), Oral Tablet
Reference Brands: Fludara® (US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
